CraigCMLawlerHMLeeCJETanMDavisDBTongJet alPREVENT: a randomized, placebo-controlled crossover trial of avexitide for treatment of postbariatric hypoglycemia
10.1111/NEP.13979 Summary Keywords safety, SGLT2 (sodium-glucose cotransporter 2) inhibitor, adverse drug (event), evidence medicine, review Citation Mascolo A, Di Napoli R, Balzano N, Cappetta D, Urbanek K, De Angelis A, Scisciola L, Di Meo I, Sullo MG, Rafaniello C and Sportiello L (2022) Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: A brief summary
Semaglutide AUC 0 t was also unaffected by combination with icodec (IcoSema/semaglutide 1.11 [1.05
Why Reduced Appetite Matters, Too When you feel full on smaller portions, total fiber and fluid intake often drops unless you deliberately replace them, and that decline lowers stool bulk and softness